Lv1
30 积分 2023-07-24 加入
Adjuvant treatment for esophageal cancer
1天前
已完结
Harnessing biomarkers to guide immunotherapy in esophageal cancer: toward precision oncology
1天前
已完结
HER2 and urothelial carcinoma: current understanding and future directions
23天前
已完结
HER2-low across solid tumours: different incidences and definitions
23天前
已完结
HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls
23天前
已完结
Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer
1个月前
已完结
Targeting claudin 18.2 in gastric cancer: a review of emerging biologic agents
1个月前
已完结
Claudin proteins as emerging therapeutic targets for solid tumours
2个月前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
2个月前
已完结
皖公网安备34019202002308
